Clinical Trials Logo

Oral Mucositis clinical trials

View clinical trials related to Oral Mucositis.

Filter by:

NCT ID: NCT04118335 Completed - Oral Mucositis Clinical Trials

Mulberry Syrup on Oral Mucositis Healing

Start date: March 9, 2017
Phase: N/A
Study type: Interventional

Objective: This study was carried out to investigate the effectiveness of oral care with black mulberry syrup on oral mucositis healing in individuals with COPD. Study Design: The quantitative part of the study was conducted as a randomized controlled experimental study, the qualitative section was conducted by in-depth interview method. The study was performed with 40 patients who were hospitalized in the Chest Diseases Clinic. In addition to the standard practice of the clinic, the individuals in the intervention group gargled with 5 ml black mulberry syrup and waited average one minute and then swallow it. They did this application 3 times a day after meals. 10 individuals in the intervention group were interviewed by using a semi-structured interview form.

NCT ID: NCT04003493 Completed - Oral Mucositis Clinical Trials

LifE Style, Nutrition and Oral Health in Care Givers (LENTO)

Start date: May 15, 2019
Phase: N/A
Study type: Interventional

The LENTO study sample includes the caregivers and their clients living in eastern Finland. The aims of this study are 1. to study the nutritional status, oral health, coping, functional capacity and quality of life 2. to find out how individual nutrition and oral health counseling received for caregivers affect on the nutritional status and oral health of caregivers and their clients 3. develop an operating model to maintain good nutrition and oral health.

NCT ID: NCT03689712 Completed - Oral Mucositis Clinical Trials

ROMAN: Phase 3 Trial Investigating the Effects of GC4419 on Radiation Induced Oral Mucositis in Head/Neck Cancer Patients

Start date: October 3, 2018
Phase: Phase 3
Study type: Interventional

The purpose of the phase 3, clinical study is to determine if GC4419 (avasopasem manganese) administered prior to intensity-modulated radiation therapy (IMRT) reduces the severity of radiation induced oral mucositis in patients who have been diagnosed with locally advanced, non-metastatic squamous cell carcinoma of the head and neck.

NCT ID: NCT03515538 Completed - Oral Mucositis Clinical Trials

Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Chemoradiation for the Treatment of Oral Cancers

PREVLAR
Start date: July 12, 2018
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine if RRx-001, which is added on to the cisplatin and radiation treatment, reduces the duration or length of severe oral mucositis in patients with head and neck cancers. All patients in this study will receive 7 weeks of standard of care radiation therapy given with the chemotherapy agent, cisplatin. Patients in arms 1, 2 and 3 will also receive RRx-001 on different schedules.

NCT ID: NCT03237325 Completed - Oral Mucositis Clinical Trials

DOM-INNATE: Study of SGX942 for the Treatment of Oral Mucositis in Patients With Concomitant Chemoradiation Therapy for Head and Neck Cancer

Start date: December 4, 2017
Phase: Phase 3
Study type: Interventional

To assess the efficacy of SGX942 compared to placebo in decreasing the duration of severe oral mucositis in patients receiving chemoradiation treatment for the treatment of head and neck cancer

NCT ID: NCT02885376 Completed - Oral Mucositis Clinical Trials

Study of Dentoxol® Mouthrinse for Oral Mucositis

Start date: November 2014
Phase: Phase 2
Study type: Interventional

The primary objective of this study is to determine the efficacy of Dentoxol® mouthrinse in reducing the severity of oral mucositis secondary to radiation therapy for head and neck cancer.

NCT ID: NCT02868151 Completed - Oral Mucositis Clinical Trials

Effect of Oral Vitamin C in Assessing the Severity of Oral Mucositis in Chemoradiation of Head and Neck Cancers

Start date: August 2016
Phase: Phase 2/Phase 3
Study type: Interventional

The surrounding controversies both advocating and simultaneously opposing the use of vitamin C, mostly extrapolating animal models to human models, it has not been used individually to assess the severity of oral mucositis during chemoradiotherapy. The present study is undertaken to evaluate the effect of vitamin C oral supplements in assessing the severity of oral mucositis during chemoradiotherapy for oral cancer.

NCT ID: NCT02630004 Completed - Oral Mucositis Clinical Trials

Melatonin Oral Gel for Oral Mucositis in Patients With Head and Neck Cancer Undergoing Chemoradiation

MUCOMEL
Start date: November 2015
Phase: Phase 1/Phase 2
Study type: Interventional

The main purpose of this study is to assess the efficacy of melatonin oral gel compared to placebo in the prevention and treatment of oral mucositis in patients with head and neck cancer undergoing concurrent chemoradiation. Other objectives are to assess the Quality of Life (QoL), to evaluate the safety and tolerability and to assess the pharmacokinetic profile of melatonin oral gel administration, in all cases compared to placebo in patients with head and neck cancer and oral mucositis secondary to concurrent chemoradiation.

NCT ID: NCT02608879 Completed - Oral Cancer Clinical Trials

Oral Care Protocol for the Management of Chemotherapy and Radiation Therapy-Induced Oral Mucositis

OMDP
Start date: March 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the effects of a novel oral care protocol on the severity and pain of oral mucositis in patients receiving radiation and/or chemotherapy for head and neck cancers. The secondary objectives are to characterize the microbiome associated with oral mucositis, measure salivary proinflammatory cytokines, and evaluate other clinical indicators of the intervention. Participants will be enrolled prior to beginning radiation and/or chemotherapy, and will be randomized to receive either the oral health protocol or standard of care oral hygiene.

NCT ID: NCT02604329 Completed - Oral Mucositis Clinical Trials

Feasibility Study of a Protocol to Treat Pediatric Oral Mucositis by Low-level Laser Therapy

PEDIALASE
Start date: December 2015
Phase: N/A
Study type: Interventional

Low Level Laser Therapy has been used for a few years in some pediatric hospital centers for chemo- and radiotherapy-induced oral mucositis care. It may promote ulceration's healing, limits mucositis severity and associated pain. As its use is recommended in the treatment of radio induced mucositis in adults, the level of evidence in pediatric studies does not allow a precise treatment protocol. The investigators present here the protocol of a feasibility study in the haemato-oncology department of the Children University Hospital of Toulouse, with the view to a future efficacy study.